PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2024-02-21

Date Title Company
21-Feb-2024 Clinical Review of Pegylated Interferons Suggests Formulation and Mechanism of Action May Improve Outcomes for MPN Patients Businesswire
21-Feb-2024 New England Journal of Medicine Publishes Results of Positive Randomized Phase 2 REVIVE Trial of Rusfertide in Treatment of Polycythemia Vera AccessWire
21-Feb-2024 Modular Medical Announces Closing of $10 Million Public Offering AccessWire
21-Feb-2024 joimax® Expands Distribution in Italy – Announces New Partnership with Uber Ros S.p.A Businesswire
21-Feb-2024 World-Leading Schizophrenia Expert Dr. Jeffrey A. Lieberman Unravels the Mysteries of Schizophrenia on The People’s Pharmacy AccessWire
21-Feb-2024 Over 5 Million Acres of Farmland Globally Use BiOWiSH® Enhanced Fertilizer Businesswire
21-Feb-2024 TriLink BioTechnologies® Solidifies IP Position with Awarded Patents for CleanCap® Capping Technology in China and Canada TriLink BioTechnologies
21-Feb-2024 Bayer Fund Awards More than $12.1M to U.S. Nonprofit Organizations in 2023, Following Latest Round of Grants Totaling $4.7M Businesswire
21-Feb-2024 Insamo Launches with $12M Funding from Playground Global, venBio, and MRL Ventures Fund to Develop Best-in-Class Membrane-Permeable Macrocyclic Peptides Businesswire
21-Feb-2024 Asia Green Biotechnology Corp. Announces Agreement to Acquire Burton Growers Ltd. and Green Sight Agri-Holdings Ltd. AccessWire
21-Feb-2024 Quest Diagnostics and Instacart Collaborate To Reduce Food Insecurity Across the United States With Integrated Patient Health Coaching and Nutritious Grocery Delivery AccessWire
21-Feb-2024 William S. Marth Joins CONTINUUS Pharmaceuticals Board of Directors, Bringing Commercial Leadership and Manufacturing Expertise to the Company Businesswire
21-Feb-2024 jCyte, Inc. Announces Positive Pre-Phase 3 FDA Type B Meeting and Outlines Plans to Start Pivotal Trial of jCell® for Retinitis Pigmentosa in the Second Half of 2024 Businesswire
21-Feb-2024 ImmunityBio Announces Full Accrual of First Two Phases of Cancer Vaccine Trial in Participants with Lynch Syndrome and Initiation of Randomized Controlled Phase of the Trial Businesswire
21-Feb-2024 Taglich Brothers Publishes First Coverage Report on Cosmos Health with a Price Target of $4, a Nearly Five-Fold Increase from Current Share Price AccessWire
21-Feb-2024 Devonian Announces the Results of its Annual General and Special Shareholders' Meeting, the Approval of Amendments to its Stock Option Plan, and Grant of Stock Options Businesswire
21-Feb-2024 Sunbird Bio to Present Positive Data from APEX Alzheimer’s Disease Diagnostic Platform at AD/PD™ 2024 Businesswire
21-Feb-2024 Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product” Businesswire
21-Feb-2024 CORRECTION: Tenon Medical, Inc. Issues Approximately $3.85 Million in Series A Preferred Stock AccessWire
21-Feb-2024 DNAnexus and Curio Bioscience Announce Collaboration to Streamline and Simplify Data Analysis for Large-Scale Spatial Transcriptomics Projects Businesswire